- Expanding FSP Solutions and Scientific Consulting Services supporting clients to achieve clinical research trial objectives faster.
Johnson City | LabConnect has announced the acquisition of A4P Consulting Ltd (A4P), a scientific consultancy firm that specialises in bioanalytical and biosample project management, biomarker strategy, and logistics solutions for preclinical and clinical trials.
The combined international team brings an unparalleled breadth and depth of technical and scientific expertise to assist clients in achieving pre-clinical and clinical trial goals sooner.
A4P is headquartered in Discovery Park, Sandwich, Kent, UK, and has a wholly-owned subsidiary in Appenzell, Switzerland. A4P serves a diverse range of clients across therapeutic areas, with core expertise in regulated bioanalysis and genomics, biomarker strategy, personalised healthcare, biosample operations, and custom logistics solutions.
“A4P was founded over 12 years ago by four individuals from the pharma industry with a vision of how Bioanalytical and Logistical consultancy could be transformed,” said Ian James, PhD., Co-Founder and Chief Executive Officer of A4P.
“Bringing together our unique company model with LabConnect unlocks exciting opportunities to broaden the geographies we operate in and enhance our service offerings for our customers. I am excited for the future for both our customers and our valued staff.”
Partnering with pharmaceutical and biotechnology companies, contract research organisations (CROs), and foundations/non-governmental organisations (NGOs), LabConnect provides innovative Central Laboratory Services and scientific Functional Service Provider (FSP) Solutions for clinical trials of all sizes and complexity across the globe.
As the requirements for clinical trials and the drug development process have become more complex, LabConnect meets these requirements by offering researchers scientific and technical expertise for all laboratory-related needs, advising on strategies for lab data collection and providing end-to-end analytical and logistical solutions tailored to each trial.
This acquisition strengthens LabConnect’s position as the industry’s leading provider of global central laboratory services and scientific-focused FSP Solutions.
“With our complementary experience, expertise, and nimble working model, our clients have unprecedented access to leading edge scientific solutions to support their pre-clinical and clinical research,” said Dawn Sherman, Chief Executive Officer of LabConnect.
“By joining forces with A4P, we further our mission to create healthier communities and improve patient lives by accelerating the development of medicines.”
LabConnect was advised by BroadOak Capital Partners and DLA Piper on the transaction. Advisors for A4P were Achelous Partners, Bishop and Sewell, Kreston Reeves, and Higson & Co.
About A4P
A4P offers scientific project management solutions and consultancy for bioanalytical and biomarker support within pre-clinical and clinical programs, and scientific logistics.
The bioanalytical project management team has expertise in working with organisations from start-up to established global entities.
A4P offers a solution to ensure on-time, in-budget and in-compliance delivery of programs. A4P logistical team provides fully customized, managed support for customers.
A4P provides outstanding service with a single proactive point of contact for management of all logistical requirements.
Published for PRNewswire on behalf of LabConnect.
Discover more from tndNews, Uganda
Subscribe to get the latest posts sent to your email.